Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2020

01-10-2020 | Lymphoma | Guideline

JSH practical guidelines for hematological malignancies, 2018: I. leukemia—3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL)

Authors: Yoshihiro Hatta, Fumihiko Hayakawa, Etsuko Yamazaki

Published in: International Journal of Hematology | Issue 4/2020

Login to get access

Excerpt

Acute leukemia and malignant lymphoma were once believed to be malignancies originating in the bone marrow and lymph nodes, respectively. Patients with lymphoblasts in the bone marrow were considered to have acute lymphoblastic leukemia (ALL), and patients without bone marrow involvement were considered to have lymphoblastic lymphoma (LBL). …
Metadata
Title
JSH practical guidelines for hematological malignancies, 2018: I. leukemia—3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL)
Authors
Yoshihiro Hatta
Fumihiko Hayakawa
Etsuko Yamazaki
Publication date
01-10-2020
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 4/2020
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-02965-z

Other articles of this Issue 4/2020

International Journal of Hematology 4/2020 Go to the issue

Images in Hematology

18FDG-PET imaging and histopathology in neuroleukemiosis with acute myeloid leukemia

Original Article

Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies

Letter to the Editor

Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab

Original Article

Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan

Original Article

Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma

Correction

Correction to: Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits